Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 30.8% in December

Ainos, Inc. (NASDAQ:AIMD) saw a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 177,100 shares, a drop of 30.8% from the December 15th total of 255,800 shares. Approximately 4.2% of the shares of the company are sold short. Based on an average daily volume of 534,600 shares, the days-to-cover ratio is currently 0.3 days.

Ainos Stock Performance

Ainos stock opened at $0.67 on Thursday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.33 and a current ratio of 1.37. The business has a 50 day simple moving average of $0.49 and a 200-day simple moving average of $0.56. Ainos has a 12 month low of $0.40 and a 12 month high of $3.10.

Ainos (NASDAQ:AIMD) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.33) EPS for the quarter. Ainos had a negative return on equity of 75.16% and a negative net margin of 15,348.14%.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.